- Synergistic Effect of Flavonoids from Artocarpus heterophyllus Heartwoods on Anticancer Activity of Cisplatin Against H460 and MCF-7 Cell Lines
-
Daud NN, Septama AW, Simbak N, Bakar NH, Rahmi EP
- KMID: 2468064
- Nat Prod Sci.
- 2019 Dec;25(4):311-316.
- doi: 10.20307/nps.2019.25.4.311
Artocarpus heterophyllus has been used as traditional medicine. This plant is one of the sources of flavonoid. Flavonoid compounds possessed a wide range of biological properties including anticancer. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- p90RSK Activation Promotes Epithelial-Mesenchymal Transition in Cisplatin-Treated Triple-Negative Breast Cancer Cells
-
Jin Y, Heo KS
- KMID: 2468028
- J Bacteriol Virol.
- 2019 Dec;49(4):221-229.
- doi: 10.4167/jbv.2019.49.4.221
p90 ribosomal S6 kinase (p90RSK), one of the downstream effectors in ERK1/2 pathways, shows high expression in human breast cancer tissues. However, its role in breast cancer development and drug... -
- CITED
-
- Close
- SHARE
-
- Close
- Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients
-
Moriya K, Namisaki T, Sato S, Furukawa M, Douhara A, Kawaratani H, Kaji K, Shimozato , Sawada Y, Saikawa S, Takaya H, Kitagawa K, Akahane T, Mitoro A, Yamao J, Yoshiji H
- KMID: 2467248
- Clin Mol Hepatol.
- 2019 Dec;25(4):381-389.
- doi: 10.3350/cmh.2019.0037
BACKGROUND AND AIMS: We previously reported the comparable efficacy of bi-monthly hepatic arterial infusion chemotherapy (B-HAIC) to that of sorafenib chemotherapy for the treatment of advanced hepatocellular carcinoma (aHCC) in... -
- CITED
-
- Close
- SHARE
-
- Close
- MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B
-
Niu Q, Liu Z, Gao J, Wang Q
- KMID: 2463793
- Yonsei Med J.
- 2019 Dec;60(12):1146-1156.
- doi: 10.3349/ymj.2019.60.12.1146
PURPOSE: Chemoresistance is a concern in ovarian cancer patients, in whom survival remains. MicroRNA, a novel class of small RNAs, have frequently been found to be dysregulated in human malignancies... -
- CITED
-
- Close
- SHARE
-
- Close
- Comments on: Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
-
Batista TP, Kusamura S
- KMID: 2458907
- J Gynecol Oncol.
- 2019 Nov;30(6):e111.
- doi: 10.3802/jgo.2019.30.e111
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of responsiveness to cancer development and anti-cancer drug in three different C57BL/6N stocks
-
Kang MJ, Kim JE, Park JW, Choi HJ, Bae SJ, Kim KS, Jung YS, Cho JY, Hwang DY, Song HK
- KMID: 2470007
- Lab Anim Res.
- 2019 Oct;35(3):114-123.
- doi: 10.1186/s42826-019-0015-z
In our efforts to understand the systemic features of tumors, the importance of animal models is increasing due to the recent growth in the development of immunotherapy and targeted therapies.... -
- CITED
-
- Close
- SHARE
-
- Close
- The Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio before Radical Radiotherapy in Patients with Non-metastatic Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis
-
Kim JS, Keam B, Heo DS, Han DH, Rhee CS, Kim JH, Jung KC, Wu HG
- KMID: 2460581
- Cancer Res Treat.
- 2019 Oct;51(4):1313-1323.
- doi: 10.4143/crt.2018.503
PURPOSE: We first analyzed the prognostic power of albumin-to-alkaline phosphatase ratio (AAPR) before radical radiotherapy (RT) in non-metastatic nasopharyngeal carcinoma (NPC) patients. MATERIALS AND METHODS: The records of 170 patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Sorafenib-induced Pancreatic Pseudocyst in a Patient with Advanced Hepatocellular Carcinoma: a Rare Adverse Event
-
Kim DH, Kim M, Yim HJ, Suh SJ, Jung YK
- KMID: 2463617
- J Liver Cancer.
- 2019 Sep;19(2):154-158.
- doi: 10.17998/jlc.19.2.154
A 54-year old man diagnosed with advanced hepatocellular carcinoma began treatment with sorafenib. After 3 weeks of treatment, he complained of abdominal pain and nausea. Abdominal sonography showed multiple hepatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Autophagy localization and cytoprotective role in cisplatin-induced acute kidney injury
-
- KMID: 2461010
- Korean J Vet Res.
- 2019 Sep;59(3):133-139.
- doi: 10.14405/kjvr.2019.59.3.133
Autophagy is a fundamental cellular process that maintains homeostasis and cell integrity, under stress conditions. Although the involvement of autophagy in various conditions has been elucidated, the role of autophagy... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
-
Kim MJ, Kim SM, Jung HA, Hong JY, Chang WJ, Choi MK, Kim HS, Sun JM, Park K, Ahn MJ
- KMID: 2457034
- Korean J Intern Med.
- 2019 Sep;34(5):1107-1115.
- doi: 10.3904/kjim.2017.234
BACKGROUND/AIMS: We investigated the efficacy and toxicity of a weekly schedule of docetaxel and cisplatin as a first-line treatment in patients with recurrent or metastatic head and neck squamous cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of genistein on anti-tumor activity of cisplatin in human cervical cancer cell lines
-
Liu H, Lee G, Lee JI, Ahn TG, Kim SA
- KMID: 2456827
- Obstet Gynecol Sci.
- 2019 Sep;62(5):322-328.
- doi: 10.5468/ogs.2019.62.5.322
OBJECTIVE: To investigate the effect of genistein on the anticancer effects of chemotherapeutic agents, we examined the effect of a genistein and cisplatin combination on CaSki human cervical cancer cells. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Nivolumab-induced Cutaneous Toxicity
-
Choi W, Myung KB, Hahn HJ, Cheong SH
- KMID: 2457689
- Korean J Dermatol.
- 2019 Aug;57(7):383-386.
Nivolumab is anti-programmed death 1 (PD1) receptor antibody, which can be used in the treatment of metastatic squamous cell cancer. By blocking the PD1 receptors on T cells, it enhances... -
- CITED
-
- Close
- SHARE
-
- Close
- Complete Remission of Metastatic Duodenal Neuroendocrine Carcinoma Treated with Chemotherapy and Surgical Resection
-
Won JH, Ryu JK
- KMID: 2455076
- Korean J Pancreas Biliary Tract.
- 2019 Jul;24(3):121-126.
- doi: 10.15279/kpba.2019.24.3.121
A 57-year-old male with periampullary duodenal mass was diagnosed as grade 3 duodenal neuroendocrine carcinoma with multiple liver metastasis. After nine cycles of cisplatin and etoposide, abdominal computed tomography (CT)... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
-
Nam AR, Jin MH, Park JE, Bang JH, Oh DY, Bang YJ
- KMID: 2454308
- Cancer Res Treat.
- 2019 Jul;51(3):1167-1179.
- doi: 10.4143/crt.2018.526
PURPOSE: The DNA damage response (DDR) is a multi-complex network of signaling pathways involved in DNA damage repair, cell cycle checkpoints, and apoptosis. In the case of biliary tract cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
-
Hyung J, Kim B, Yoo C, Kim KP, Jeong JH, Chang HM, Ryoo BY
- KMID: 2454282
- Cancer Res Treat.
- 2019 Jul;51(3):901-909.
- doi: 10.4143/crt.2018.326
PURPOSE: Gemcitabine plus cisplatin (GemCis) is the standard first-line chemotherapy for patients with advanced biliary tract cancer (BTC). In ABC-02 study, the BTC patients received up to 6-8 cycles of... -
- CITED
-
- Close
- SHARE
-
- Close
- Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer
-
Nam AR, Kim JW, Park JE, Bang JH, Jin MH, Oh DY, Bang YJ
- KMID: 2454281
- Cancer Res Treat.
- 2019 Jul;51(3):886-900.
- doi: 10.4143/crt.2018.375
PURPOSE: Jab1 is a coactivator of c-Jun that enhances the transcriptional function of c-Jun. Jab1 is frequently overexpressed in various cancers and is associatedwith poor prognosis of cancer patients. Thus,... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy
-
Hue H, Kim K, Kim H, Suh DH, No JH, Kim YB
- KMID: 2451659
- Obstet Gynecol Sci.
- 2019 Jul;62(4):285-289.
- doi: 10.5468/ogs.2019.62.4.285
The long-term survival of heavily pretreated patients with primary peritoneal cancer (PPC) is uncommon. Here, we report on a patient with PPC refractory to multiple lines of intravenous chemotherapy, namely,... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice
-
Liu H, Lee JI, Ahn TG
- KMID: 2451653
- Obstet Gynecol Sci.
- 2019 Jul;62(4):242-248.
- doi: 10.5468/ogs.2019.62.4.242
OBJECTIVE: The purpose of this study was to determine the effect of quercetin on the antitumor activity of cisplatin and its side-effects. METHODS: EMT6 cells, a mouse breast cancer cell line,... -
- CITED
-
- Close
- SHARE
-
- Close
- A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial
-
Tangjitgamol S, Tharavichitkul E, Tovanabutra C, Rongsriyam K, Asakij T, Paengchit , Sukhaboon , Penpattanagul S, Kridakara , Hanprasertpong J, Chomprasert K, Wanglikitkoon S, Atjimakul , Pariyawateekul P, Katanyoo K, Tanprasert P, Janweerachai W, Sangthawan D, Khunnarong J, Chottetanaprasith T, Supawattanabodee B, Lertsanguansinchai P, Srisomboon J, Isaranuwatchai W, Lorvidhaya V
- KMID: 2450246
- J Gynecol Oncol.
- 2019 Jul;30(4):e82.
- doi: 10.3802/jgo.2019.30.e82
OBJECTIVE: To compare response rate and survivals of locally advanced stage cervical cancer patients who had standard concurrent chemoradiation therapy (CCRT) alone to those who had adjuvant chemotherapy (ACT) after... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
-
Petrillo M, Zucchetti , Cianci S, Morosi L, Ronsini C, Colombo A, D'Incalci , Scambia G, Fagotti A
- KMID: 2450238
- J Gynecol Oncol.
- 2019 Jul;30(4):e59.
- doi: 10.3802/jgo.2019.30.e59
OBJECTIVE: Evidences from animal models seem to suggest that minimally invasive surgery may enhance cisplatin diffusion when the drug is administered in the context of post-operative hyperthermic intraperitoneal chemotherapy (HIPEC).... -
- CITED
-
- Close
- SHARE
-
- Close
